Search results

Jump to navigation Jump to search
Results 1 – 100 of 105
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Did you mean: with serotonin syndrome

  • Dosage
    0218_files/flexiweigh_balance_accuracy.pdf Scales - TripSit wiki  3-MeO-PCP - TripSit wiki  Responsible drug use index
    5 KB (1,438 words) - 23:18, 21 April 2024
  • 25x-NBOMe (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    6 KB (1,847 words) - 00:06, 16 May 2024
  • Research chemicals
    combine it with other MAOIs, stimulants and certain substances which release serotonin or dopamine. It is recommended to avoid blends or branded products if the
    19 KB (2,209 words) - 23:08, 21 April 2024
  • MDMA (section Serotonin syndrome risk)
    with the following substances can lead to dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    85 KB (10,499 words) - 14:24, 16 April 2024
  • 6-APB (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    33 KB (4,870 words) - 14:34, 16 April 2024
  • Tripsitting index (category PsychonautWiki)
    life-threatening condition known as neuroleptic malignant syndrome. MDMA-AP Serotonin syndrome treatment: Common Psychonautics Responsible use Psychoactive
    905 bytes (619 words) - 20:57, 24 April 2023
  • Main Page (section Please don't crawl the wiki. Use our API instead.PsychonautWiki ❤️ Developers. Please report any obstacles.)
    Melatonin ⋅ Neuron ⋅ Neurotransmitter ⋅ Noradrenaline ⋅ Receptor ⋅ Serotonin ⋅ Serotonin syndrome ⋅ Substance P ⋅ Synapse Dreams ⋅ Dream characters ⋅ Dream signs
    21 KB (1,004 words) - 23:38, 13 May 2024
  • Dosage measurement
    0218_files/flexiweigh_balance_accuracy.pdf Scales - TripSit wiki  3-MeO-PCP - TripSit wiki  Ask Erowid : ID 2282 : How big is a milligram?  Erowid Psychoactives
    9 KB (1,092 words) - 23:18, 21 April 2024
  • Methamphetamine
    hyperpyrexia, pulmonary hypertension, renal failure, rhabdomyolysis, serotonin syndrome, and a form of stereotypy ("tweaking"). A methamphetamine overdose
    41 KB (5,798 words) - 13:29, 16 April 2024
  • 25I-NBOMe
    ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
    28 KB (4,417 words) - 14:00, 16 April 2024
  • Responsible drug use
    http://www.americanweigh.com/pdf/manuals/gemini-20_manual.pdf 3-MeO-PCP - TripSit wiki  Erowid Psychoactive Vaults : Liquid Measurement Technique  Erowid. "25I-NBOMe
    37 KB (3,944 words) - 23:17, 21 April 2024
  • Reagent testing kits
    Ecstasy Testing Kit FAQ (Erowid) Colorimetric reagent results (DMT-Nexus Wiki) How to Reagent Test guide (Reddit) Test results for all drugs & substances
    23 KB (1,192 words) - 17:50, 19 March 2024
  • 4-FMA
    produces its effects by increasing levels of dopamine, norepinephrine, and serotonin in the brain. 4-FMA was first detected being sold in Japan as a legal high
    21 KB (3,467 words) - 16:14, 30 July 2022
  • MDPV
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    23 KB (3,267 words) - 23:45, 21 April 2024
  • Tramadol (section Serotonin syndrome risk)
    may cause serotonin syndrome. DXM - Dextromethorphan has SRI properties. Because Tramadol has SNRI activity and it also has slight serotonin releasing
    22 KB (3,211 words) - 19:11, 7 April 2024
  • NBx (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    27 KB (1,991 words) - 18:31, 18 September 2022
  • Antidepressants (section Selective serotonin reuptake inhibitors (SSRIs))
    inhibitors (NDRIs) Selective serotonin reuptake inhibitors (SSRIs) Serotonin and norepinephrine reuptake inhibitors (SNRIs) Serotonin antagonist and reuptake
    9 KB (1,069 words) - 21:47, 13 May 2024
  • Opioids
    the mu receptors with serotonin, dopamine, and norepinephrine. Activation of mu receptors allows for the disinhibition of serotonin and dopamine neurons
    19 KB (2,797 words) - 02:47, 12 May 2024
  • DMT
    complete hallucinations. It is thought to produce its effects by binding to serotonin receptors in the brain, although the precise mechanism is not fully understood
    58 KB (7,681 words) - 22:15, 14 May 2024
  • Selective serotonin reuptake inhibitor
    and AMT can result in serotonin syndrome. Tramadol - Combining an SSRI with tramadol can cause seizures and serotonin syndrome. Other antidepressants
    15 KB (1,687 words) - 18:59, 22 November 2023
  • Methylone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,841 words) - 14:21, 16 April 2024
  • Psychedelic
    similarity to the serotonin molecule. It has a higher affinity than serotonin itself for the receptors, therefore preventing serotonin from binding to the
    31 KB (3,363 words) - 22:58, 21 April 2024
  • 3-MMC (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,590 words) - 21:20, 30 April 2024
  • Mephedrone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    29 KB (3,963 words) - 14:23, 16 April 2024
  • MDA (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    31 KB (4,379 words) - 12:23, 6 May 2024
  • 6-APDB (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    26 KB (4,015 words) - 23:44, 21 April 2024
  • MDAI (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,560 words) - 07:40, 12 October 2023
  • Dextromethorphan
    additional synergistic effects. MAOIs - High risk of serotonin syndrome. SSRIs - High risk of serotonin syndrome. Antihistamines - Many H1 antagonists, including
    66 KB (8,370 words) - 12:29, 7 May 2024
  • A-PHP (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    21 KB (3,212 words) - 09:58, 30 May 2023
  • A-PVP (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    24 KB (3,456 words) - 00:08, 3 November 2023
  • 5-MeO-DMT
    Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    26 KB (3,619 words) - 19:56, 7 April 2024
  • 5-MAPB (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    13 KB (2,233 words) - 00:32, 31 December 2022
  • MDEA (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    25 KB (3,654 words) - 23:46, 21 April 2024
  • Diphenhydramine
    K (October 2008). "Serotonin reuptake inhibition by diphenhydramine and concomitant linezolid use can result in serotonin syndrome". Chest. 134 (4 Meeting
    33 KB (4,164 words) - 20:42, 12 May 2024
  • Fentanyl (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    21 KB (3,331 words) - 23:49, 21 April 2024
  • 5-APB (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    14 KB (2,336 words) - 23:43, 21 April 2024
  • Ephylone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,604 words) - 22:15, 31 July 2022
  • Tapentadol (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    12 KB (2,182 words) - 23:51, 21 April 2024
  • Methadone (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    17 KB (2,924 words) - 23:50, 21 April 2024
  • TMA-6 (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    12 KB (1,570 words) - 21:03, 19 July 2022
  • Dextropropoxyphene (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    10 KB (2,015 words) - 23:49, 21 April 2024
  • 5-MeO-MiPT
    Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    22 KB (2,938 words) - 21:31, 14 November 2023
  • PMMA
    MAO-A and at the same time releasing large amounts of serotonin, effectively causing serotonin syndrome. It appears that PMMA activates the hypothalamus much
    10 KB (1,254 words) - 09:30, 28 December 2022
  • Butylone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,647 words) - 23:46, 21 April 2024
  • O-Desmethyltramadol (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    13 KB (2,437 words) - 07:14, 27 December 2023
  • Pethidine (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    13 KB (2,295 words) - 12:34, 29 April 2024
  • Pregabalin
    nausea, and a flu-like feeling. One report of a patient entering serotonin syndrome following perioperative Oxycodone and pregabalin exists. However,
    41 KB (5,211 words) - 12:50, 15 March 2024
  • MCPP (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,483 words) - 19:42, 10 October 2023
  • Ethylone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,532 words) - 22:27, 31 July 2022
  • NEP (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,677 words) - 06:56, 28 April 2024
  • PMA
    MAO-A and at the same time releasing large amounts of serotonin, effectively causing serotonin syndrome. It appears that PMA activates the hypothalamus much
    10 KB (2,183 words) - 19:02, 2 August 2022
  • Acetylfentanyl (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    22 KB (3,397 words) - 23:49, 21 April 2024
  • Methoxetamine
    use of intelligent drug design, as a potential treatment for Phantom Limb Syndrome among other ailments. MXE had no documented history of human usage until
    23 KB (2,917 words) - 00:54, 19 September 2023
  • Ayahuasca
    As a result of its MAOI effects, ayahuasca is more likely to induce serotonin syndrome or general neurotransmitter overload (especially at high dosages)
    33 KB (3,884 words) - 07:33, 16 November 2023
  • Scientific information
    agonists MAOI RIMA Modulator Piperidines Phenylpropenes Prodrugs Racetams Serotonin syndrome SSRI SNRI Synthetic cannabinoids Vagus nerve Hormone Neuron Neurotransmitter
    599 bytes (162 words) - 23:00, 21 April 2024
  • 2C-T
    MAOI effects this could indicate that 2C-T is more likely to induce serotonin syndrome or general neurotransmitter overload (especially at high dosages)
    13 KB (1,528 words) - 23:08, 29 May 2021
  • 5-MeO-DiPT
    Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    16 KB (2,115 words) - 09:35, 3 September 2022
  • 2-FEA
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    13 KB (1,917 words) - 18:16, 30 April 2024
  • Efavirenz (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    10 KB (1,224 words) - 23:39, 21 April 2024
  • LSD
    May increase the risk of anxiety, delusions, mania, psychosis, and serotonin syndrome. Cannabis: Cannabis has a strong, volatile synergy with LSD. While
    100 KB (12,100 words) - 08:20, 3 January 2024
  • 2C-T-2 (category PsychonautWiki articles needing factual verification from October 2020)
    [citation needed] this could indicate that 2C-T-2 is more likely to induce serotonin syndrome or general neurotransmitter overload (especially at high dosages)
    22 KB (2,627 words) - 23:08, 29 May 2021
  • 3-FPM
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    15 KB (2,265 words) - 06:42, 8 September 2023
  • Cannabis
    dependence characterized by the occurrence of a withdrawal syndrome after abstinence. This withdrawal syndrome was found to peak 2-3 days after quitting and is mostly
    65 KB (8,816 words) - 18:09, 27 April 2024
  • Myristicin
    generally recommended against. Serotonin releasers such as MDMA, 4-FA, methamphetamine, methylone and αMT will cause serotonin syndrome. If planning to combine
    19 KB (2,523 words) - 07:09, 16 November 2023
  • 2C-T-7
    serious adverse effects seen on overdoses of this compound (potentially Serotonin Syndrome) and as the 2,5-desmethoxy derivative of 2C-T-7 has been shown to
    22 KB (2,709 words) - 23:09, 29 May 2021
  • Ketobemidone (section Serotonin syndrome risk)
    with the following substances can cause dangerously high serotonin levels. Serotonin syndrome requires immediate medical attention and can be fatal if
    7 KB (1,696 words) - 07:26, 4 December 2021
  • 1cP-LSD
    toxicity by the serotonin 2A receptior partial agonist d-lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    27 KB (3,642 words) - 18:48, 12 November 2022
  • Harmala alkaloid
    sometimes fatal interactions with many common drugs. They can cause serotonin syndrome or hypertensive crisis when combined with almost any antidepressant
    13 KB (1,772 words) - 02:21, 24 September 2023
  • 5-MeO-DALT
    Tramadol - Increased risk of serotonin syndrome. aMT - Increased risk of serotonin syndrome. MAOIs - Increased risk of serotonin syndrome. PCP - Little information
    16 KB (2,263 words) - 23:37, 21 April 2024
  • 2-Aminoindane
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    12 KB (1,928 words) - 23:42, 21 April 2024
  • Modafinil
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (3,104 words) - 11:29, 16 April 2024
  • Mexedrone (section Serotonin syndrome risk)
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    10 KB (1,757 words) - 23:45, 21 April 2024
  • Methylphenidate
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    31 KB (4,254 words) - 15:15, 6 May 2024
  • 1V-LSD
    toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    28 KB (3,658 words) - 15:27, 10 March 2023
  • Tianeptine
    increase levels of serotonin in subjects. Rather, it has been found to increase the reuptake of serotonin, being labeled a selective serotonin reuptake enhancer
    20 KB (2,399 words) - 00:17, 6 May 2024
  • Prolintane
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    11 KB (1,751 words) - 20:42, 12 September 2022
  • Psilocybin mushrooms
    toxicity by the serotonin 2A receptior partial agonist d-lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    67 KB (8,112 words) - 22:04, 6 May 2024
  • Desoxypipradrol
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,776 words) - 00:39, 1 August 2022
  • 4F-MPH
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    16 KB (2,465 words) - 15:45, 9 May 2024
  • Ethylphenidate
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (2,561 words) - 14:02, 16 April 2024
  • 1P-LSD
    toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor antagonist
    36 KB (4,688 words) - 09:41, 10 May 2024
  • N-Methylbisfluoromodafinil
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    8 KB (1,534 words) - 19:22, 2 August 2022
  • Cyclazodone
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,675 words) - 16:54, 31 March 2024
  • 3,4-CTMP
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    24 KB (3,701 words) - 23:42, 21 April 2024
  • Propylhexedrine
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    20 KB (2,813 words) - 21:23, 25 October 2023
  • 4F-EPH
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,757 words) - 17:49, 30 July 2022
  • NM-2-AI
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    11 KB (1,914 words) - 23:46, 21 April 2024
  • Isopropylphenidate
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    19 KB (2,684 words) - 18:04, 30 July 2022
  • 2C-T-21
    speculated, this could indicate that 2C-T-21 is more likely to induce serotonin syndrome or general neurotransmitter overload (especially at high dosages)
    18 KB (2,002 words) - 06:06, 12 August 2022
  • Quetiapine
    clinically negligible anticholinergic properties. Quetiapine binds strongly to serotonin receptors; the drug acts as partial agonist at 5-HT1A receptors. In terms
    26 KB (3,070 words) - 00:36, 28 April 2024
  • Cocoa
    amounts which could cause high blood pressure or less potentially, serotonin syndrome. Cocoa powder can be legally obtained likely in every country, although
    10 KB (1,095 words) - 23:12, 9 May 2024
  • Methiopropamine
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    13 KB (2,010 words) - 00:43, 1 August 2022
  • GHB
    ISSN 0306-5251.  Laborit, H. (January 1972). "Correlations between protein and serotonin synthesis during various activities of the central nervous system (slow
    35 KB (4,460 words) - 13:32, 16 April 2024
  • Methylnaphthidate
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    9 KB (1,564 words) - 23:45, 21 April 2024
  • Armodafinil
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    18 KB (3,163 words) - 18:25, 30 April 2024
  • N-Ethylhexedrone
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    25 KB (3,455 words) - 23:45, 21 April 2024
  • 2C-B-FLY
    effects, this could indicate that 2C-B-FLY is more likely to induce serotonin syndrome or general monoamine overload (especially at high dosages) than other
    21 KB (2,764 words) - 23:36, 21 April 2024
  • ETH-CAT
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    17 KB (2,584 words) - 12:23, 5 April 2024
  • Mirtazapine
    types of antidepressants can cause adverse effects as well as possible serotonin syndrome when mixed. Mirtazapine is legally approved for medical purposes worldwide
    32 KB (3,698 words) - 18:07, 7 April 2024
  • Tyrosine
    on serotonin and norepinephrine reuptake. There is an increased risk of panic attacks and hypertensive crisis, or serotonin syndrome with serotonin releasers
    14 KB (2,109 words) - 23:22, 21 April 2024

View (previous 100 | next 100) (20 | 50 | 100 | 250 | 500)

Retrieved from ‘https://psychonautwiki.org/wiki/Special:Search’